Press Releases

DUBLIN--(BUSINESS WIRE)-- The "Global Passenger Car Market - by Type, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)" report has been added to ResearchAndMarkets.com's offering. The global passenger car market will reach 1,703.7 billion USD by 2023

DUBLIN--(BUSINESS WIRE)-- The "Global Field Programmable Gate Array Market - by Type, Technology, Industry, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)" report has been added to ResearchAndMarkets.com's offering. The global field programmable gate a

SAN JOSE, Calif.--(BUSINESS WIRE)-- Cypress Semiconductor Corp. (NASDAQ: CY), the embedded solutions leader, today announced that global automotive supplier Yazaki North America has implemented Cypress’ instrument cluster solution to drive the advanced graphics in its instrument cluster for a leading American car manufacturer. Yazaki selected Cypress based on its unique offering of five chips that combine

SEOUL, South Korea--(BUSINESS WIRE)-- Hyosung Chairman Hyun Joon Cho has propelled the revival of Hyosung Group (KRX:004800)’s heavy industries business by pursuing

HEMEL HEMPSTEAD, England--(BUSINESS WIRE)-- EUSA Pharma (EUSA) welcomes the news that FOTIVDA®▼ (tivozanib) is expected to be included in the upcoming European Society of Medical Oncology (ESMO) clinical practice guidelines for advanced renal cell carcinoma (aRCC), anticipated to be published at the end of this year.1 The outline of the new proposed guidelines was prese

EGGENSTEIN-LEOPOLDSHAFEN, Germany--(BUSINESS WIRE)-- amcure, a biopharmaceutical company developing first-in-class cancer therapeutics, presented clinical trial data from its lead oncology drug candidate, AMC303, at the European Society for Medical Oncology (ESMO) Congress in Munich. The data presented on Sunday, 21 October in a proffered oral presentation demonstrated the favorable safety profile of AMC303. Th

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive results from the Phase III IMpower130 study of Tecentriq® (atezolizumab) plus chemotherapy (carboplatin and Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of people with previously untreated

SAN LEANDRO, Calif.--(BUSINESS WIRE)-- BioClin Therapeutics, Inc., a privately-held clinical stage drug development company, today announced its participation in the BTIG Biotech Conference taking place at the Langham Hotel in New York. Dr. Graeme Currie, Ph.D., Chief Operating Officer, will participate in a panel “Targeted Oncology Therapies – Material Advancements, Intriguing Potenti

LITTLETON, Mass.--(BUSINESS WIRE)-- Mevion Medical System announces that construction is underway for a second proton therapy system at Siteman Cancer Center at Barne

SAN JOSE, Calif.--(BUSINESS WIRE)-- Vocera Communications, Inc. (NYSE:VCRA), a recognized leader in clinical communication and workflow solutions, today anno

MINNEAPOLIS--(BUSINESS WIRE)-- Polaris Industries Inc. (NYSE: PII): (Downloadable PDF of this p

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) today announced new data from a cohort of the CheckMate -142 study in which Opdivo (n

SEATTLE--(BUSINESS WIRE)-- Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading immunotherapy company, presented positive results from preclinical studies of its lead program ALPN-101, a dual ICOS/CD28 antagonist, in experimental models of inflammatory arthritis and multiple sclerosis. The data were presented on Sunday, October 21, 2018 in poster sessions during the 2018 American College of Rheumatology (ACR)/

TORONTO--(BUSINESS WIRE)-- Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV: ATE, OTCQB: ATBPF), a leader in developing safer therapeutics for pain and inflammation, is pleased to announce that it has established a strategic advisory board to support its business development activities. “We are very pleased to welcome four superb pharma executives to our team of advisors w

SANTA ROSA, Calif.--(BUSINESS WIRE)-- Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that helps enterprises, service providers, and governments accelerate innovation to connect and secure the world, announced a new